Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoxetine suppresses human cataplexy: a pilot study

J Frey1, C Darbonne

  • 1Division of Neurology, Barrow Neurological Institute, Phoenix, AZ 85013.

Neurology
|April 1, 1994
PubMed
Summary

Fluoxetine effectively treats cataplexy, significantly reducing weekly episodes by 92% in a pilot study. This antidepressant medication offers a safe alternative, minimizing the need for other treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The canopy: a novel vertical airflow device with ceramic wall flow filters for reducing airborne pathogen spread in hospital rooms.

The Journal of hospital infection·2025
Same author

Auditory spatial cueing reduces neglect after right-hemispheric stroke: A proof of concept study.

Cortex; a journal devoted to the study of the nervous system and behavior·2022
Same author

First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.

Journal of endocrinological investigation·2021
Same author

Biomimetic reconstruction of the hematopoietic stem cell niche for in vitro amplification of human hematopoietic stem cells.

PloS one·2020
Same author

High risk of permanent stoma after anastomotic leakage in anterior resection for rectal cancer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
Same author

Causes of mortality and morbidity in free-ranging mustelids in Switzerland: necropsy data from over 50 years of general health surveillance.

BMC veterinary research·2018

Area of Science:

  • Neurology
  • Pharmacology
  • Sleep Medicine

Background:

  • Cataplexy, a symptom of narcolepsy, is often poorly controlled with existing medications.
  • Anticataplectic agents can have undesirable side effects and varying efficacy.

Observation:

  • A pilot study investigated fluoxetine's efficacy in six patients with poorly controlled cataplexy.
  • Patients received an initial dose of 20 mg fluoxetine without altering their current medication regimen.

Findings:

  • Fluoxetine treatment resulted in a mean reduction of 92% in weekly cataplectic episodes after 20 weeks.
  • Five out of six patients reported no side effects, with one experiencing mild headache.
  • The study demonstrated fluoxetine's ability to suppress cataplexy effectively and safely.

Implications:

  • Fluoxetine presents a promising and safe therapeutic option for managing cataplexy.
  • This finding may reduce reliance on other anticataplectic medications with potentially more severe side effects.
  • Further research is warranted to confirm these findings in larger patient cohorts.

Related Experiment Videos